Advanced search
Publication Cover
Molecular Membrane Biology Volume 23, 2006 - Issue 5
Journal homepage
2,871
Views
137
CrossRef citations to date
0
Altmetric
Original

Immunostimulation of dendritic cells by cationic liposomes

Dileep P. Vangasseri Center for Pharmacogenetics, School of Pharmacy, Pittsburgh, Pennsylvania, USA
,
Zhengrong Cui Center for Pharmacogenetics, School of Pharmacy, Pittsburgh, Pennsylvania, USA
,
Weihsu Chen Center for Pharmacogenetics, School of Pharmacy, Pittsburgh, Pennsylvania, USA
,
David A. Hokey Department of Dermatology, , Pittsburgh, Pennsylvania, USA; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
,
Louis D. Falo Jr Department of Dermatology, , Pittsburgh, Pennsylvania, USA; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
&
Leaf Huang Center for Pharmacogenetics, School of Pharmacy, Pittsburgh, Pennsylvania, USACorrespondence[email protected]
, PhD
Pages 385-395 | Received 01 Nov 2005, Published online: 09 Jul 2009

Citations (137)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (15)

Hengameh Firouzmand, Mehrnosh Sahranavard, Ali Badiee, Ali Khamesipour, Seyedeh Hoda Alavizadeh, Afshin Samiei, Dina Soroush, Masoumeh Tavassoti Kheiri, Fereidoun Mahboudi & Mahmoud Reza Jaafari. (2018) The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model. Immunopharmacology and Immunotoxicology 40:1, pages 72-82.
Read now
Jiemin Wang, Xiongbin Hu & Daxiong Xiang. (2018) Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines. Drug Delivery 25:1, pages 1319-1327.
Read now
Yun Hu, Hong Zheng, Wei Huang & Chenming Zhang. (2014) A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle. Human Vaccines & Immunotherapeutics 10:1, pages 64-72.
Read now
Sarah Gordon, Katherine Young, Rachel Wilson, Shakila Rizwan, Roslyn Kemp, Thomas Rades & Sarah Hook. (2012) Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems. Journal of Liposome Research 22:3, pages 193-204.
Read now
Delaram Doroud & Sima Rafati. (2012) Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. Expert Review of Vaccines 11:1, pages 69-86.
Read now
Myrra G. Carstens, Koen van der Maaden,Daniel van der Velden,Tom H.M. Ottenhoff, Cornelis J. Melief, Ferry Ossendorp, Joke A. Bouwstra & Wim Jiskoot. (2011) Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes. Journal of Liposome Research 21:4, pages 286-295.
Read now
Josianne Nitcheu Tefit & Vincent Serra. (2011) Outlining novel cellular adjuvant products for therapeutic vaccines against cancer. Expert Review of Vaccines 10:8, pages 1207-1220.
Read now
Dennis Christensen, Karen Smith Korsholm, Peter Andersen & Else Marie Agger. (2011) Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines 10:4, pages 513-521.
Read now
Malou Henriksen-Lacey, Karen Smith Korsholm, Peter Andersen, Yvonne Perrie & Dennis Christensen. (2011) Liposomal vaccine delivery systems. Expert Opinion on Drug Delivery 8:4, pages 505-519.
Read now
Matthew Black, Amanda Trent, Matthew Tirrell & Colleen Olive. (2010) Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists. Expert Review of Vaccines 9:2, pages 157-173.
Read now
Joost H. van den Berg, Bastiaan Nuijen, Ton N. Schumacher, John B.A.G. Haanen, Gert Storm, Jos H. Beijnen & Wim E. Hennink. (2010) Synthetic vehicles for DNA vaccination. Journal of Drug Targeting 18:1, pages 1-14.
Read now
Pernille Nordly, Henriette Baun Madsen, Hanne Moerck Nielsen & Camilla Foged. (2009) Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opinion on Drug Delivery 6:7, pages 657-672.
Read now
Dennis Christensen, Else Marie Agger, Lars Vibe Andreasen, Daniel Kirby, Peter Andersen & Yvonne Perrie. (2009) Liposome-based cationic adjuvant formulations (CAF): Past, present, and future. Journal of Liposome Research 19:1, pages 2-11.
Read now
Steven Dow. (2008) Liposome–nucleic acid immunotherapeutics. Expert Opinion on Drug Delivery 5:1, pages 11-24.
Read now
Dennis Christensen, Karen S Korsholm, Ida Rosenkrands, Thomas Lindenstrøm, Peter Andersen & Else Marie Agger. (2007) Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines 6:5, pages 785-796.
Read now

Articles from other publishers (122)

Sangiliyandi Gurunathan, Pratheep Thangaraj, Lin Wang, Qilong Cao & Jin-Hoi Kim. (2024) Nanovaccines: An effective therapeutic approach for cancer therapy. Biomedicine & Pharmacotherapy 170, pages 115992.
Crossref
Yeji Lee, Michaela Jeong, Jeongeun Park, Hyein Jung & Hyukjin Lee. (2023) Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Experimental & Molecular Medicine 55:10, pages 2085-2096.
Crossref
Jing Liu, Juan Jiang, Caiguanxi Deng, Xinshuo Huang, Shuang Huang, Zhengjie Liu, Jiang Yang, Jingshan Mo, Hui‐jiuan Chen, Ji Wang & Xi Xie. (2023) Nanochannel Electro‐Injection as a Versatile Platform for Efficient RNA/DNA Programming on Dendritic Cells. Small 19:43.
Crossref
Yangyang Zhao, Qunjie Bi, Yu Wei, Ruohan Wang, Gang Wang, Gang Fu, Zhiguang Ran, Jiao Lu, Heyang Zhang, Ling Zhang, Rongrong Jin & Yu Nie. (2023) A DNA vaccine (EG95-PT1/2/3-IL2) encoding multi-epitope antigen and IL-2 provokes efficient and long-term immunity to echinococcosis. Journal of Controlled Release 361, pages 402-416.
Crossref
Junwoo Lee & Dongwoo Khang. (2023) Mucosal delivery of nanovaccine strategy against COVID-19 and its variants. Acta Pharmaceutica Sinica B 13:7, pages 2897-2925.
Crossref
Xue Jiang, Jiaojiao Zhang, Pik Kwan Lo & Zhengwei Mao. (2023) Polyphenol‐Based Assembly Nanosystems as Multifunctional Biopharmaceutical Platform. Advanced NanoBiomed Research 3:6.
Crossref
Saurabh Shah, Paras Famta, Vinod Tiwari, Arun K. Kotha, Rama Kashikar, Mahavir Bhupal Chougule, Young Hun Chung, Nicole F. Steinmetz, Mohammad Uddin, Shashi Bala Singh & Saurabh Srivastava. (2022) Instigation of the epoch of nanovaccines in cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 15:3.
Crossref
Kuo-Ching Mei, Rebeca T. Stiepel, Emily Bonacquisti, Natalie E. Jasiewicz, Ameya Pravin Chaudhari, Palas B. Tiwade, Eric M. Bachelder, Kristy M. Ainslie, Owen S. Fenton & Juliane Nguyen. (2023) Single-tailed heterocyclic carboxamide lipids for macrophage immune-modulation. Biomaterials Science 11:8, pages 2693-2698.
Crossref
Sahar Tahaghoghi-Hajghorbani, Mona Yazdani, Amin Reza Nikpoor, Mahdi Hatamipour, Abolghasem Ajami, Mahmoud Reza Jaafari, Ali Badiee & Alireza Rafiei. (2023) Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine. Scientific Reports 13:1.
Crossref
Xinghua Huang, Jianwei Li, Guanyi Li, Binyu Ni, Ziji Liang, Haodong Chen, Chaozhang Xu, Jianhua Zhou, Jinsheng Huang & Shaohui Deng. (2023) Cation-free siRNA-cored nanocapsules for tumor-targeted RNAi therapy. Acta Biomaterialia 161, pages 226-237.
Crossref
Mohammad Zaki Ahmad, Javed Ahmad, Ahmad Umar, Basel A. Abdel-Wahab, Ahmed A. Lahiq, Zufesha NoorulHuda Khan, Kalyani Pathak, Md Rizwanullah, Musarrat Hussain Warsi, Riya Saikia, Manash Pratim Pathak & Sheheryar Munir. (2023) Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer. Science of Advanced Materials 15:3, pages 285-318.
Crossref
Siva K. Gandhapudi, Hua Shi, Martin R. Ward, John Peyton Bush, Margarita Avdiushko, Karuna Sundarapandiyan, Lauren V. Wood, Mania Dorrani, Afsheen Fatima, Joe Dervan, Frank Bedu-Addo, Greg Conn, Ted M. Ross & Jerold G. Woodward. (2023) Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses 15:2, pages 432.
Crossref
Ahmed A.H. Abdellatif, Mahmoud A. Younis, Abdullah F. Alsowinea, Emad M. Abdallah, Mohamed S. Abdel-Bakky, Amal Al-Subaiyel, Yasser A.H. Hassan & Hesham M. Tawfeek. (2023) Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine. Colloids and Surfaces B: Biointerfaces 222, pages 113111.
Crossref
Harun Achmad, Yousif Saleh Ibrahim, Muataz Mohammed Al-Taee, Gamal A. Gabr, Muhammad Waheed Riaz, Shadia Hamoud Alshahrani, Andrés Alexis Ramírez-Coronel, Abduladheem Turki Jalil, Hendrik Setia Budi, Windi Sawitri, Malyutina Elena Stanislavovna & Jitendra Gupta. (2022) Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting. International Immunopharmacology 113, pages 109434.
Crossref
Abdul Rahim Ferhan, Soohyun Park, Hyeonjin Park, Hyunhyuk Tae, Joshua A. Jackman & Nam‐Joon Cho. (2022) Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective. Advanced Functional Materials 32:37.
Crossref
Xingliang Fang, Huanrong Lan, Ketao Jin, Daojun Gong & Jun Qian. (2022) Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review. Cancers 14:16, pages 3842.
Crossref
Gérard Milano, Federico Innocenti & Hironobu Minami. (2022) Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. Cancer Science 113:7, pages 2224-2231.
Crossref
Penghua Li, Liqun Wang, Meng Sun, Jiyuan Yao, Wenhui Li, Wangting Lu, Youhua Zhou, Geng Zhang, Chenglong Hu, Wanquan Zheng & Feng Wei. (2022) Binding affinity and conformation of a conjugated AS1411 aptamer at a cationic lipid bilayer interface. Physical Chemistry Chemical Physics 24:15, pages 9018-9028.
Crossref
Yi‐Chung Chang, Chi‐Fan Yang, Yi‐Fen Chen, Chia‐Chun Yang, Yuan‐Lin Chou, Hung‐Wen Chou, Tein‐Yao Chang, Tai‐Ling Chao, Shu‐Chen Hsu, Si‐Man Ieong, Ya‐Min Tsai, Ping‐Cheng Liu, Yuan‐Fan Chin, Jun‐Tung Fang, Han‐Chieh Kao, Hsuan‐Ying Lu, Jia‐Yu Chang, Ren‐Shiuan Weng, Qian‐Wen Tu, Fang‐Yu Chang, Kuo‐Yen Huang, Tong‐Young Lee, Sui‐Yuan Chang & Pan‐Chyr Yang. (2022) A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant. EMBO Molecular Medicine 14:4.
Crossref
Jia Tan, Binbin Ding, Bo Teng, Ping'an Ma & Jun Lin. (2022) Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy. Advanced Functional Materials 32:16.
Crossref
Yuyan Zhang, Yingying Hu, Huayu Tian & Xuesi Chen. (2022) Opportunities and Challenges for mRNA Delivery Nanoplatforms. The Journal of Physical Chemistry Letters 13:5, pages 1314-1322.
Crossref
Mona Yazdani, Amin Reza Nikpoor, Zahra Gholizadeh, Nema Mohamadian Roshan, Alexander Seifalian, Mahmoud Reza Jaafari & Ali Badiee. (2021) Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model. International Immunopharmacology 98, pages 107833.
Crossref
Danielle E. Large, Rudolf G. Abdelmessih, Elizabeth A. Fink & Debra T. Auguste. (2021) Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Advanced Drug Delivery Reviews 176, pages 113851.
Crossref
Arindam K. Dey, Adrien Nougarède, Flora Clément, Carole Fournier, Evelyne Jouvin-Marche, Marie Escudé, Dorothée Jary, Fabrice P. Navarro & Patrice N. Marche. (2021) Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery. Frontiers in Immunology 12.
Crossref
Pandian Sureshbabu Ram Kumar, Clayton Fernando Rencilin & Krishnan Sundar. (2021) Emerging nanomaterials for cancer immunotherapy. Exploration of Medicine 2:3, pages 208-231.
Crossref
Botond Z Igyártó, Sonya Jacobsen & Sonia Ndeupen. (2021) Future considerations for the mRNA-lipid nanoparticle vaccine platform. Current Opinion in Virology 48, pages 65-72.
Crossref
Cassandra E. Callmann, Caroline D. Kusmierz, Jasper W. Dittmar, Leah Broger & Chad A. Mirkin. (2021) Impact of Liposomal Spherical Nucleic Acid Structure on Immunotherapeutic Function. ACS Central Science 7:5, pages 892-899.
Crossref
Noémi Anna Nagy, Aram M. de Haas, Teunis B. H. Geijtenbeek, Ronald van Ree, Sander W. Tas, Yvette van Kooyk & Esther C. de Jong. (2021) Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance. Frontiers in Immunology 12.
Crossref
Jeroen Heuts, Wim Jiskoot, Ferry Ossendorp & Koen van der Maaden. (2021) Cationic Nanoparticle-Based Cancer Vaccines. Pharmaceutics 13:5, pages 596.
Crossref
Yan Yang, Saisai Yue, Yuanyuan Qiao, Peisen Zhang, Ni Jiang, Zhenbo Ning, Chunyan Liu & Yi Hou. (2021) Activable Multi-Modal Nanoprobes for Imaging Diagnosis and Therapy of Tumors. Frontiers in Chemistry 8.
Crossref
Hyungjun Kim, Simseok A. Yuk, Alexandra M. Dieterly, Soonbum Kwon, Jinho Park, Fanfei Meng, Hytham H. Gadalla, Maria Jose Cadena, L. Tiffany Lyle & Yoon Yeo. (2021) Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors. ACS Nano 15:3, pages 4576-4593.
Crossref
Seo Ri Wui, Ara Ko, Ji In Ryu, Eojin Sim, Soo Jeong Lim, Shin Ae Park, Kwang Sung Kim, Ha Kim, Hyewon Youn & Na Gyong Lee. (2021) The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes. Pharmaceutics 13:3, pages 390.
Crossref
Xuemei Ge, Lijuan Chen, Bo Zhao & Weien Yuan. (2021) Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA. Frontiers in Pharmacology 11.
Crossref
Chun Chan, Shi Du, Yizhou Dong & Xiaolin Cheng. (2021) Computational and Experimental Approaches to Investigate Lipid Nanoparticles as Drug and Gene Delivery Systems. Current Topics in Medicinal Chemistry 21:2, pages 92-114.
Crossref
Lana Papafilippou, Andrew Claxton, Paul Dark, Kostas Kostarelos & Marilena Hadjidemetriou. (2020) Nanotools for Sepsis Diagnosis and Treatment. Advanced Healthcare Materials 10:1, pages 2001378.
Crossref
Floriane Auderset, Elodie Belnoue, Beatris Mastelic-Gavillet, Paul-Henri Lambert & Claire-Anne Siegrist. (2020) A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner. Frontiers in Immunology 11.
Crossref
Zili Gu, Candido Da Silva, Koen Van der Maaden, Ferry Ossendorp & Luis Cruz. (2020) Liposome-Based Drug Delivery Systems in Cancer Immunotherapy. Pharmaceutics 12:11, pages 1054.
Crossref
Bwalya A. Witika, Pedzisai A. Makoni, Scott K. Matafwali, Billy Chabalenge, Chiluba Mwila, Aubrey C. Kalungia, Christian I. Nkanga, Alain M. Bapolisi & Roderick B. Walker. (2020) Biocompatibility of Biomaterials for Nanoencapsulation: Current Approaches. Nanomaterials 10:9, pages 1649.
Crossref
Mona Yazdani, Zahra Gholizadeh, Amin Reza Nikpoor, Mahdi Hatamipour, Behrang Alani, Hossein Nikzad, Nema Mohamadian Roshan, Javad Verdi, Mahmoud Reza Jaafari, Mahdi Noureddini & Ali Badiee. (2020) Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma. Vaccine 38:35, pages 5665-5677.
Crossref
Xiuxiu Cong, Huimin Tian, Shuhan Liu, Kuirong Mao, Hongmei Chen, Yanbao Xin, Feiqi Liu, Xin Wang, Xiandi Meng, Ge Zhu, Jialiang Wang, Xue Gao, Huizhu Tan, Yong-Guang Yang & Tianmeng Sun. (2020) Cationic Liposome/DNA Complexes Mediate Antitumor Immunotherapy by Promoting Immunogenic Tumor Cell Death and Dendritic Cell Activation. ACS Applied Materials & Interfaces 12:25, pages 28047-28056.
Crossref
C. Wyatt ShieldsIVIV, Lily Li‐Wen Wang, Michael A. Evans & Samir Mitragotri. (2019) Materials for Immunotherapy. Advanced Materials 32:13.
Crossref
Hannah J. Vaughan, Jordan J. Green & Stephany Y. Tzeng. (2019) Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery. Advanced Materials 32:13.
Crossref
Michael-Joseph Gorbet & Ashish Ranjan. (2020) Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacology & Therapeutics 207, pages 107456.
Crossref
Stephany Y. TzengKisha K. PatelDavid R. WilsonRandall A. MeyerKelly R. RhodesJordan J. Green. (2020) In situ genetic engineering of tumors for long-lasting and systemic immunotherapy. Proceedings of the National Academy of Sciences 117:8, pages 4043-4052.
Crossref
Zhenfu Wen, Fengyu Liu, Qing Chen, Yongqian Xu, Hongjuan Li & Shiguo Sun. (2019) Recent development in biodegradable nanovehicle delivery system-assisted immunotherapy. Biomaterials Science 7:11, pages 4414-4443.
Crossref
Thibault Colombani, Thomas Haudebourg, Marion Decossas, Olivier Lambert, Grace Ada Da Silva, Frederic Altare & Bruno Pitard. (2019) Lipidic Aminoglycoside Derivatives: A New Class of Immunomodulators Inducing a Potent Innate Immune Stimulation. Advanced Science 6:16.
Crossref
Siva K. Gandhapudi, Martin Ward, John Peyton C. Bush, Frank Bedu-Addo, Greg Conn & Jerold G. Woodward. (2019) Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response. The Journal of Immunology 202:12, pages 3524-3536.
Crossref
Seo Ri Wui, Kwang Sung Kim, Ji In Ryu, Ara Ko, Hien Thi Thu Do, Yeon Jung Lee, Hark Jun Kim, Soo Jeong Lim, Shin Ae Park, Yang Je Cho, Chang-Gyeom Kim & Na Gyong Lee. (2019) Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice. Vaccine 37:15, pages 2131-2141.
Crossref
Reza Mahjub, Sukhdeep Jatana, Suen Ern Lee, Zhu Qin, Griffin Pauli, Meysam Soleimani, Soheil Madadi & Shyh-Dar Li. (2018) Recent advances in applying nanotechnologies for cancer immunotherapy. Journal of Controlled Release 288, pages 239-263.
Crossref
Parvin Zamani, Amir Abbas Momtazi‐Borojeni, Maryam Ebrahimi Nik, Reza Kazemi Oskuee & Amirhossein Sahebkar. (2018) Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy. Journal of Cellular Physiology 233:7, pages 5189-5199.
Crossref
Farzad Khademi, Ramezan Ali Taheri, Amir Abbas Momtazi-Borojeni, Gholamreza Farnoosh, Thomas P. Johnston & Amirhossein Sahebkar. 2018. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175 47 69 .
Sung Duk Jo, Gi-Hoon Nam, Gijung Kwak, Yoosoo Yang & Ick Chan Kwon. (2017) Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy. Nano Today 17, pages 23-37.
Crossref
Markus Riehl, Meike Harms, Andrea Hanefeld, Renato B. Baleeiro, Peter Walden & Karsten Mäder. (2017) Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies. International Journal of Pharmaceutics 532:1, pages 37-46.
Crossref
Tatjana Michel, Daniel Luft, Meike-Kristin Abraham, Sabrina Reinhardt, Martha L. Salinas Medina, Julia Kurz, Martin Schaller, Meltem Avci-Adali, Christian Schlensak, Karlheinz Peter, Hans Peter Wendel, Xiaowei Wang & Stefanie Krajewski. (2017) Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications. Molecular Therapy - Nucleic Acids 8, pages 459-468.
Crossref
Thomas Courant, Emilie Bayon, Hei Lanne Reynaud-Dougier, Christian Villiers, Mathilde Menneteau, Patrice N. Marche & Fabrice P. Navarro. (2017) Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies. Biomaterials 136, pages 29-42.
Crossref
Bingbing Sun, Zhaoxia Ji, Yu-Pei Liao, Chong Hyun Chang, Xiang Wang, Justine Ku, Changying Xue, Vahid Mirshafiee & Tian Xia. (2017) Enhanced Immune Adjuvant Activity of Aluminum Oxyhydroxide Nanorods through Cationic Surface Functionalization. ACS Applied Materials & Interfaces 9:26, pages 21697-21705.
Crossref
V.M. Berlin Grace & S. Viswanathan. (2017) Pharmacokinetics and therapeutic efficiency of a novel cationic liposome nano-formulated all trans retinoic acid in lung cancer mice model. Journal of Drug Delivery Science and Technology 39, pages 223-236.
Crossref
Malvina Pizzuto, Monique Gangloff, Daniel Scherman, Nicholas J. Gay, Virginie Escriou, Jean-Marie Ruysschaert & Caroline Lonez. (2017) Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers. Journal of Controlled Release 247, pages 182-193.
Crossref
A.M. Carmona-Ribeiro. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development 241 257 .
Silke Neumann, Simon A. Shirley, Roslyn A. Kemp & Sarah M. Hook. (2016) Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone. Frontiers in Immunology 7.
Crossref
Saeedeh Najafi-Hajivar, Parvin Zakeri-Milani, Hamed Mohammadi, Mehri Niazi, Mehdi Soleymani-Goloujeh, Behzad Baradaran & Hadi Valizadeh. (2016) Overview on experimental models of interactions between nanoparticles and the immune system. Biomedicine & Pharmacotherapy 83, pages 1365-1378.
Crossref
Jinho Park, Joonyoung Park, Yihua Pei, Jun Xu & Yoon Yeo. (2016) Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Advanced Drug Delivery Reviews 104, pages 93-109.
Crossref
Catarina Carneiro, Alexandra Correia, Tânia Lima, Manuel Vilanova, Célia Pais, Andreia C. Gomes, M. Elisabete C.D. Real Oliveira & Paula Sampaio. (2016) Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. Acta Biomaterialia 39, pages 133-145.
Crossref
Eric Farris, Deborah M Brown, Amanda E Ramer-Tait & Angela K Pannier. (2016) Micro- and nanoparticulates for DNA vaccine delivery. Experimental Biology and Medicine 241:9, pages 919-929.
Crossref
Natt Tasaniyananda, Urai Chaisri, Anchalee Tungtrongchitr, Wanpen Chaicumpa & Nitat Sookrung. (2016) Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. PLOS ONE 11:3, pages e0150463.
Crossref
Eleni Maria Varypataki, Ana Luisa Silva, Christophe Barnier-Quer, Nicolas Collin, Ferry Ossendorp & Wim Jiskoot. (2016) Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles. Journal of Controlled Release 226, pages 98-106.
Crossref
Ronnie H. Fang, Ashley V. Kroll & Liangfang Zhang. (2015) Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy. Small 11:41, pages 5483-5496.
Crossref
Silke Neumann, Katie Young, Benji Compton, Regan Anderson, Gavin Painter & Sarah Hook. (2015) Synthetic TRP2 long-peptide and α-galactosylceramide formulated into cationic liposomes elicit CD8 + T-cell responses and prevent tumour progression. Vaccine 33:43, pages 5838-5844.
Crossref
Peter C. Soema, Geert-Jan Willems, Wim Jiskoot, Jean-Pierre Amorij & Gideon F. Kersten. (2015) Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 427-435.
Crossref
Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle & Roberto Gasparini. 2015. 231 322 .
Ruchi R Shah, Derek T O'Hagan, Mansoor M Amiji & Luis A Brito. (2014) The impact of size on particulate vaccine adjuvants. Nanomedicine 9:17, pages 2671-2681.
Crossref
Julio Rodriguez Lavado, Stefania E. Sestito, Roberto Cighetti, Eva M. Aguilar Moncayo, Alja Oblak, Duško Lainšček, José Luis Jiménez Blanco, José Manuel García Fernández, Carmen Ortiz Mellet, Roman Jerala, Valentina Calabrese & Francesco Peri. (2014) Trehalose- and Glucose-Derived Glycoamphiphiles: Small-Molecule and Nanoparticle Toll-Like Receptor 4 (TLR4) Modulators. Journal of Medicinal Chemistry 57:21, pages 9105-9123.
Crossref
Anne Endmann, Detlef Oswald, Oliver Riede, Eduard G. Talman, Roelien E. Vos, Matthias Schroff, Christiane Kleuss, Marcel H.J. Ruiters & Christiane Juhls. (2014) Combination of MIDGE-Th1 DNA vaccines with the cationic lipid SAINT-18: Studies on formulation, biodistribution and vector clearance. Vaccine 32:27, pages 3460-3467.
Crossref
Yutaka Ikeda & Yukio Nagasaki. (2014) Impacts of PEGylation on the gene and oligonucleotide delivery system. Journal of Applied Polymer Science 131:9, pages n/a-n/a.
Crossref
Caroline Lonez, Michel Bessodes, Daniel Scherman, Michel Vandenbranden, Virginie Escriou & Jean-Marie Ruysschaert. (2014) Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways. Nanomedicine: Nanotechnology, Biology and Medicine 10:4, pages 775-782.
Crossref
Derrick P. McCarthy, Zoe N. Hunter, Bryce Chackerian, Lonnie D. Shea & Stephen D. Miller. (2014) Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 6:3, pages 298-315.
Crossref
Bruno M.D.C. Godinho, David J. McCarthy, Cristina Torres-Fuentes, Caroll J. Beltrán, Joanna McCarthy, Aoife Quinlan, Julien R. Ogier, Raphael Darcy, Caitriona M. O'Driscoll & John F. Cryan. (2014) Differential nanotoxicological and neuroinflammatory liabilities of non-viral vectors for RNA interference in the central nervous system. Biomaterials 35:1, pages 489-499.
Crossref
Yi Zhao & Leaf Huang. 2014. Nonviral Vectors for Gene Therapy - Lipid- and Polymer-based Gene Transfer. Nonviral Vectors for Gene Therapy - Lipid- and Polymer-based Gene Transfer 13 36 .
Yoshikazu Inoh, Satoshi Tadokoro, Hiroki Tanabe, Makoto Inoue, Naohide Hirashima, Mamoru Nakanishi & Tadahide Furuno. (2013) Inhibitory effects of a cationic liposome on allergic reaction mediated by mast cell activation. Biochemical Pharmacology 86:12, pages 1731-1738.
Crossref
Hengameh Firouzmand, Ali Badiee, Ali Khamesipour, Vahid Heravi Shargh, Seyedeh Hoda Alavizadeh, Azam Abbasi & Mahmoud Reza Jaafari. (2013) Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA). Acta Tropica 128:3, pages 528-535.
Crossref
Dan Peer. (2013) A daunting task: manipulating leukocyte function with RNA i . Immunological Reviews 253:1, pages 185-197.
Crossref
Zhenyu Zhong, Yougang Zhai, Shuang Liang, Yasuo Mori, Renzhi Han, Fayyaz S. Sutterwala & Liang Qiao. (2013) TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nature Communications 4:1.
Crossref
Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski & Istvan Toth. (2012) Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine 7:12, pages 1877-1893.
Crossref
Dan Peer. (2012) Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles. Advanced Drug Delivery Reviews 64:15, pages 1738-1748.
Crossref
Caroline Lonez, Michel Vandenbranden & Jean-Marie Ruysschaert. (2012) Cationic lipids activate intracellular signaling pathways. Advanced Drug Delivery Reviews 64:15, pages 1749-1758.
Crossref
L. Figueiredo, A. Cadete, L.M.D. Gonçalves, M.L. Corvo & A.J. Almeida. (2012) Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems. Vaccine 30:46, pages 6551-6558.
Crossref
Dalit Landesman-Milo & Dan Peer. (2012) Altering the immune response with lipid-based nanoparticles. Journal of Controlled Release 161:2, pages 600-608.
Crossref
Vahid Heravi Shargh, Mahmoud Reza Jaafari, Ali Khamesipour, Seyed Amir Jalali, Hengameh Firouzmand, Azam Abbasi & Ali Badiee. (2012) Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. Parasitology Research 111:1, pages 105-114.
Crossref
Vahid Heravi Shargh, Mahmoud Reza Jaafari, Ali Khamesipour, Iman Jaafari, Seyed Amir Jalali, Azam Abbasi & Ali Badiee. (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine 30:26, pages 3957-3964.
Crossref
Yan Zhuang, Yifan Ma, Ce Wang, Luo Hai, Chao Yan, Yijuan Zhang, Fengzhi Liu & Lintao Cai. (2012) PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. Journal of Controlled Release 159:1, pages 135-142.
Crossref
Alena Wieber, Torsten Selzer & Jörg Kreuter. (2012) Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying. European Journal of Pharmaceutics and Biopharmaceutics 80:2, pages 358-367.
Crossref
Gilles Bioley, Philippe Bussat, Anne Lassus, Michel Schneider, Jacques Terrettaz & Blaise Corthésy. (2012) The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells. Biomaterials 33:1, pages 333-342.
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology 135 178 .
Alena Wieber, Torsten Selzer & Jörg Kreuter. (2011) Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: A comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes. International Journal of Pharmaceutics 421:1, pages 151-159.
Crossref
Malou Henriksen-Lacey, Andrew Devitt & Yvonne Perrie. (2011) The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production. Journal of Controlled Release 154:2, pages 131-137.
Crossref
Leaf Huang & Yang Liu. (2011) In Vivo Delivery of RNAi with Lipid-Based Nanoparticles. Annual Review of Biomedical Engineering 13:1, pages 507-530.
Crossref
Nijaporn Yanasarn, Brian R. Sloat & Zhengrong Cui. (2011) Negatively Charged Liposomes Show Potent Adjuvant Activity When Simply Admixed with Protein Antigens. Molecular Pharmaceutics 8:4, pages 1174-1185.
Crossref
T. Behera, P. Swain & S.K. Sahoo. (2011) Antigen in chitosan coated liposomes enhances immune responses through parenteral immunization. International Immunopharmacology 11:8, pages 907-914.
Crossref
Gerd Lipowsky & Martin F. Bachmann. 2011. Development of Vaccines. Development of Vaccines 19 63 .
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, Yasaman Taslimi, Rouholah Vahabpour, Fatemeh Torkashvand, Behrooz Vaziri, Abdolhossein Rouholamini Najafabadi & Sima Rafati. (2011) C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice. PLoS Neglected Tropical Diseases 5:7, pages e1236.
Crossref
Delaram Doroud, Farnaz Zahedifard, Alireza Vatanara, Abdolhossein Rouholamini Najafabadi, Yasaman Taslimi, Rouholah Vahabpour, Fatemeh Torkashvand, Behrooz Vaziri & Sima Rafati. (2011) Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection. Journal of Controlled Release 153:2, pages 154-162.
Crossref
Myrra G. Carstens, Marcel G.M. Camps, Malou Henriksen-Lacey, Kees Franken, Tom H.M. Ottenhoff, Yvonne Perrie, Joke A. Bouwstra, Ferry Ossendorp & Wim Jiskoot. (2011) Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 29:29-30, pages 4761-4770.
Crossref
Malou Henriksen-Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2010) Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[ N -( N ′, N ′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses . Molecular Pharmaceutics 8:1, pages 153-161.
Crossref
Wei-Yun Sheng & Leaf Huang. (2010) Cancer Immunotherapy and Nanomedicine. Pharmaceutical Research 28:2, pages 200-214.
Crossref
Yifan Ma, Yan Zhuang, Xiaofang Xie, Ce Wang, Fei Wang, Dongmei Zhou, Jianqiang Zeng & Lintao Cai. (2011) The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Nanoscale 3:5, pages 2307.
Crossref
Malou Henriksen-Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2010) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. Journal of Controlled Release 145:2, pages 102-108.
Crossref
Jean Haensler. 2010. Vaccine Adjuvants. Vaccine Adjuvants 73 90 .
Ranit Kedmi & Dan Peer. (2009) RNAi nanoparticles in the service of personalized medicine. Nanomedicine 4:8, pages 853-855.
Crossref
Camilla Foged, Pieter Vader & Raymond M. Schiffelers. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals 291 304 .
Yifan Ma, Dongmei Zhou, Xiaofang Xie, Bohan Dong, Yan Zhuang & Mingbin Zheng. (2009) A novel low-toxic liposomal adjuvant: Different liposome compositions regulate monocyte activation and viability. A novel low-toxic liposomal adjuvant: Different liposome compositions regulate monocyte activation and viability.
Jukka Hartikka, Vesselina Bozoukova, Catherine K. Yang, Ming Ye, Denis Rusalov, Mark Shlapobersky, Adrian Vilalta, Qun Wei, Alain Rolland & Larry R. Smith. (2009) Vaxfectin®, a cationic lipid-based adjuvant for protein-based influenza vaccines. Vaccine 27:46, pages 6399-6403.
Crossref
Caroline Lonez, Marc F. Lensink, Michel Vandenbranden & Jean-Marie Ruysschaert. (2009) Cationic lipids activate cellular cascades. Which receptors are involved?. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:6, pages 425-430.
Crossref
Shili Liu, Kenny K. Tran, Steven Pan & Hong Shen. (2009) Detecting and differentiating microbes by dendritic cells for the development of cell-based biosensors. Biosensors and Bioelectronics 24:8, pages 2598-2603.
Crossref
Weili Yan & Leaf Huang. (2009) The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome. International Journal of Pharmaceutics 368:1-2, pages 56-62.
Crossref
Caroline Lonez, Michel Vandenbranden & Jean-Marie Ruysschaert. (2008) Cationic liposomal lipids: From gene carriers to cell signaling. Progress in Lipid Research 47:5, pages 340-347.
Crossref
Weili Yan, Weihsu Chen & Leaf Huang. (2008) Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine. Journal of Controlled Release 130:1, pages 22-28.
Crossref
Jun Ren, Jun Jia, Hongmei Zhang, Liwang Zhang, Bo Ma, Hanfang Jiang, Lijun Di, Guohong Song & Jing Yu. (2008) Dendritic cells pulsed with ?-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma. Cancer Science 99:7, pages 1420-1426.
Crossref
Tetsuya Tanaka, Amandine Legat, Emmanuelle Adam, Jonathan Steuve, Jean-Stéphane Gatot, Michel Vandenbranden, Liliana Ulianov, Caroline Lonez, Jean-Marie Ruysschaert, Eric Muraille, Marcel Tuynder, Michel Goldman & Alain Jacquet. (2008) DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4. European Journal of Immunology 38:5, pages 1351-1357.
Crossref
Lakshmi Krishnan & G. Dennis Sprott. (2008) Archaeosome adjuvants: Immunological capabilities and mechanism(s) of action. Vaccine 26:17, pages 2043-2055.
Crossref
Weihsu Chen, Weili Yan & Leaf Huang. (2007) A simple but effective cancer vaccine consisting of an antigen and a cationic lipid. Cancer Immunology, Immunotherapy 57:4, pages 517-530.
Crossref
Weili Yan, Weihsu Chen & Leaf Huang. (2007) Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines. Molecular Immunology 44:15, pages 3672-3681.
Crossref
Karen Smith Korsholm, Else Marie Agger, Camilla Foged, Dennis Christensen, Jes Dietrich, Claire Swetman Andersen, Carsten Geisler & Peter Andersen. (2007) The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology 121:2, pages 216-226.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.